liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimers disease
Linköping University, Department of Neuroscience and Locomotion, Pathology. Linköping University, Faculty of Health Sciences.
Prince of Wales Medical Research Institute.
Linköping University, Department of Clinical and Experimental Medicine, Experimental Pathology . Linköping University, Faculty of Health Sciences.
Prince of Wales Medical Research Institute.
Show others and affiliations
2010 (English)In: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, ISSN 1388-1981, E-ISSN 1388-1918, Vol. 1801, no 8, 831-838 p.Article in journal (Refereed) Published
Abstract [en]

The Niemann-Pick type Cl (NPC1) protein mediates the trafficking of cholesterol from lysosomes to other organelles. Mutations in the NPC1 gene lead to the retention of cholesterol and other lipids in the lysosomal compartment, and such defects are the basis of NPC disease. Several parallels exist between NPC disease and Alzheimers disease (AD), including altered cholesterol homeostasis, changes in the lysosomal system, neurofibrillary tangles, and increased amyloid-beta generation. How the expression of NPC1 in the human brain is affected in AD has not been investigated so far. In the present study, we measured NPC1 mRNA and protein expression in three distinct regions of the human brain, and we revealed that NPC1 expression is upregulated at both mRNA and protein levels in the hippocampus and frontal cortex of AD patients compared to control individuals. In the cerebellum, a brain region that is relatively spared in AD, no difference in NPC1 expression was detected. Similarly, murine NPC1 mRNA levels were increased in the hippocampus of 12-month-old transgenic mice expressing a familial AD form of human amyloid-beta precursor protein (APP) and presenilin-1 (APP/PS1tg) compared to 12-month-old wild type mice, whereas no change in NPC1 was detected in mouse cerebellum. Immunohistochemical analysis of human hippocampus indicated that NPC1 expression was strongest in neurons. However, in vitro studies revealed that NPC1 expression was not induced by transfecting SK-N-SH neurons with human APP or by treating them with oligomeric amyloid-beta peptide. Total cholesterol levels were reduced in hippocampus from AD patients compared to control individuals, and it is therefore possible that the increased expression of NPC1 is linked to perturbed cholesterol homeostasis in AD.

Place, publisher, year, edition, pages
ELSEVIER SCIENCE BV , 2010. Vol. 1801, no 8, 831-838 p.
Keyword [en]
Alzheimers disease; Niemann-Pick; Cholesterol; Lysosome; CA1; Hippocampus; Cerebellum; Frontal cortex
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-58275DOI: 10.1016/j.bbalip.2010.05.005ISI: 000279476000012OAI: diva2:337934
Available from: 2010-08-10 Created: 2010-08-09 Last updated: 2010-09-17

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Kågedal, KatarinaAppelqvist, HannaAgholme, Lotta
By organisation
PathologyFaculty of Health SciencesExperimental Pathology Geriatric Department of Geriatrics
In the same journal
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 40 hits
ReferencesLink to record
Permanent link

Direct link